In the last 12 months, insiders at Xtant Medical Holdings, Inc. ($XTNT) filed 36 transactions with the SEC: 0 open-market purchases totaling $0 and 2 sales totaling $30,708,129. Net insider sentiment: net selling.
Xtant Medical Holdings, Inc. operates in the Surgical & medical instruments & apparatus industry (Industrial Applications and Services sector).
Most Active Insiders
- ORBIMED ADVISORS LLC (TenPercentOwner) — 2 transactions totaling $30,708,129
- Browne Sean E (President and CEO) — 7 transactions totaling $189,133
- Brandt Kevin D (Chief Commercial Officer) — 2 transactions totaling $33,800
- Neils Scott C (Chief Financial Officer) — 4 transactions totaling $33,417
- Neils Scott C (CFO) — 1 transaction totaling $21,503
View all SEC Filings for Xtant Medical Holdings, Inc. (XTNT).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 15, 2026 | Schallenberger Mark A. | Chief Operating Officer | F | Common Stock | 7709 | $0.58 | 663,157.0000 | 150,377,234 | 1.15% | 0.01% |
| Jan. 15, 2026 | Neils Scott C | CFO and Assistant Secretary | F | Common Stock | 8084 | $0.65 | 843,381.0000 | 150,377,234 | 0.95% | 0.01% |
| Nov. 15, 2025 | Neils Scott C | CFO and Assistant Secretary | A | Performance Stock Units (PSUs) | 526582 | $0.00 | 526,582.0000 | 150,377,234 | 9999.99% | 0.35% |
| Nov. 15, 2025 | BAKEWELL JOHN K | Director | A | Common Stock | 158228 | $0.00 | 914,116.0000 | 150,377,234 | 20.93% | 0.11% |
| Nov. 15, 2025 | Vizirgianakis Stavros G. | Director | A | Common Stock | 553797 | $0.00 | 7,515,570.0000 | 150,377,234 | 7.95% | 0.37% |
| Nov. 15, 2025 | Beeson Jonn R. | Director | A | Common Stock | 158228 | $0.00 | 1,532,891.0000 | 150,377,234 | 11.51% | 0.11% |
| Nov. 15, 2025 | BAKEWELL JOHN K | Director | A | Common Stock | 158228 | $0.00 | 158,228.0000 | 150,377,234 | 9999.99% | 0.11% |
| Nov. 15, 2025 | JAIN ABHINAV | Director | A | Common Stock | 158228 | $0.00 | 158,228.0000 | 150,377,234 | 9999.99% | 0.11% |
| Nov. 15, 2025 | Lipschultz Tyler | Director | A | Common Stock | 158228 | $0.00 | 158,228.0000 | 150,377,234 | 9999.99% | 0.11% |
| Nov. 15, 2025 | Browne Sean E | President and CEO | A | Common Stock | 394937 | $0.00 | 2,575,274.0000 | 150,377,234 | 18.11% | 0.26% |
| Nov. 15, 2025 | Browne Sean E | President and CEO | A | Performance Stock Units (PSUs) | 789874 | $0.00 | 789,874.0000 | 150,377,234 | 9999.99% | 0.53% |
| Nov. 15, 2025 | Schallenberger Mark A. | Chief Operating Officer | A | Common Stock | 292253 | $0.00 | 670,866.0000 | 150,377,234 | 77.19% | 0.19% |
| Nov. 15, 2025 | Schallenberger Mark A. | Chief Operating Officer | A | Performance Stock Units (PSUs) | 584506 | $0.00 | 584,506.0000 | 150,377,234 | 9999.99% | 0.39% |
| Nov. 15, 2025 | Neils Scott C | CFO and Assistant Secretary | A | Common Stock | 263291 | $0.00 | 851,465.0000 | 150,377,234 | 44.76% | 0.18% |
| Aug. 15, 2025 | Neils Scott C | CFO | F | Common Stock | 34131 | $0.63 | 588,174.0000 | 133,665,075 | 5.48% | 0.03% |
| Aug. 15, 2025 | Browne Sean E | President and CEO | F | Common Stock | 10605 | $0.63 | 2,180,337.0000 | 133,665,075 | 0.48% | 0.01% |
| April 10, 2025 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 17109618 | $0.42 | 0.0000 | 133,665,075 | 100.00% | 12.80% |
| April 10, 2025 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 56004974 | $0.42 | 0.0000 | 133,665,075 | 100.00% | 41.90% |
| April 3, 2024 | Schallenberger Mark A. | Chief Operations Officer | A | Common Stock | 173469 | $0.00 | 378,613.0000 | 126,793,318 | 84.56% | 0.14% |
| Jan. 15, 2025 | Neils Scott C | Chief Financial Officer | F | Common Stock | 7986 | $0.53 | 622,305.0000 | 133,665,075 | 1.27% | 0.01% |
| Oct. 15, 2024 | Browne Sean E | President and CEO | F | Common Stock | 105442 | $0.59 | 2,190,942.0000 | 135,100,233 | 4.59% | 0.08% |
| Aug. 15, 2024 | Brandt Kevin D | Chief Commercial Officer | F | Common Stock | 56333 | $0.60 | 943,736.0000 | 126,793,318 | 5.63% | 0.04% |
| Aug. 15, 2024 | Browne Sean E | President and CEO | F | Common Stock | 10606 | $0.60 | 2,296,384.0000 | 126,793,318 | 0.46% | 0.01% |
| Aug. 15, 2024 | Neils Scott C | Chief Financial Officer | F | Common Stock | 34132 | $0.60 | 630,291.0000 | 126,793,318 | 5.14% | 0.03% |
| Aug. 15, 2024 | Vizirgianakis Stavros G. | Director | A | Common Stock | 243243 | $0.00 | 6,456,368.0000 | 126,793,318 | 3.91% | 0.19% |
| Aug. 15, 2024 | Vizirgianakis Stavros G. | Director | A | Common Stock | 505405 | $0.00 | 6,961,773.0000 | 126,793,318 | 7.83% | 0.40% |
| Aug. 15, 2024 | MITCHELL-KELLER LORI D | Director | A | Common Stock | 162162 | $0.00 | 353,124.0000 | 126,793,318 | 84.92% | 0.13% |
| Aug. 15, 2024 | McNamara Robert | Director | A | Common Stock | 162162 | $0.00 | 754,151.0000 | 126,793,318 | 27.39% | 0.13% |
| Aug. 15, 2024 | Beeson Jonn R. | Director | A | Common Stock | 162162 | $0.00 | 1,374,663.0000 | 126,793,318 | 13.37% | 0.13% |
| Aug. 15, 2024 | BAKEWELL JOHN K | Director | A | Common Stock | 162162 | $0.00 | 755,888.0000 | 126,793,318 | 27.31% | 0.13% |
| April 3, 2024 | Schallenberger Mark A. | Chief Operations Officer | A | Common Stock | 177551 | $0.00 | 382,695.0000 | 126,793,318 | 86.55% | 0.14% |
| April 3, 2024 | Brandt Kevin D | Chief Commercial Officer | A | Common Stock | 184209 | $0.00 | 1,000,069.0000 | 126,793,318 | 22.58% | 0.15% |
| April 3, 2024 | Browne Sean E | President and CEO | A | Common Stock | 731632 | $0.00 | 2,306,990.0000 | 126,793,318 | 46.44% | 0.58% |
| April 3, 2024 | Neils Scott C | Chief Financial Officer | A | Common Stock | 177551 | $0.00 | 664,423.0000 | 126,793,318 | 36.47% | 0.14% |
| Oct. 15, 2023 | Browne Sean E | President and CEO | F | Common Stock | 105442 | $1.08 | 1,575,358.0000 | 0 | 6.27% | 0.00% |
| Jan. 16, 2024 | Neils Scott C | Chief Financial Officer | F | Common Stock | 7986 | $1.09 | 486,872.0000 | 126,793,318 | 1.61% | 0.01% |